The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction
Open accessAbstract
Converging preclinical, and human epidemiological, neuroimaging, and genetic evidence suggests a central role for dopamine neurotransmission in modulating pain perception and analgesia. Dysregulation in dopamine signaling may modulate the experience of pain both directly, by enhancing or diminishing the propagation of nociceptive signals, and indirectly, by influencing affective and cognitive processes, which affect the expectation, experience, and interpretation of nociceptive signals. Hypersensitivity to pain and high rates of comorbid chronic pain are common in disorders linked with deficits in dopamine system function, including disorders of mood and affect, substance abuse, and Parkinson disease. Hyposensitivity to pain, however, is common in patients with schizophrenia, which has been linked with excessive dopamine neurotransmission. Although patients are typically affected most by the primary symptoms of their disorders, alterations in pain perception may further increase the burden of their illness, compromising their quality of life. The present review focuses on this relationship, and discusses clinical and potential therapeutic implications for both patients with dopamine-related disorders and those with chronic pain syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Crombez, G., Vlaeyen, J. W. S., Heuts, P. H. T. G., & Lysens, R. (1999) · Pain · doi:10.1016/s0304-3959(98)00229-2 · Cited by 1,675
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606 · cited 1×
“individuals in response to monetary reward (reviewed by [123]).”
BackgroundHow does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505 · cited 1×
“dependent on heroin, cocaine, nicotine, or alcohol (reviewed by [147]).”
BackgroundMultiple dopamine functions at different time courses
Schultz, W. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135722 · Cited by 1,415 · cited 2×
“Tonic DA levels, which are defined by the amount of DA present at steady-state concentrations in extra-synaptic space [47,137], exert an enabling influence on post-synaptic receptors, which impact the motor, cognitive, and motivational systems often affected by Parkinson disease [137].”
BackgroundPain catastrophizing: a critical review.
Quartana, P. J., Campbell, C. M., & Edwards, R. R. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.34 · Cited by 1,405
Enzymatic O-methylation of epinephrine and other catechols
Axelrod, J., & Tomchick, R. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64731-3 · Cited by 1,283 · cited 1×
“For instance, since COMT also plays an important role in degrading norepinephrine and epinephrine [7], it has been suggested that presence of the Val allele may promote more rapid degradation of”
BackgroundDiatchenko, L., Slade, G. D., Nackley, A. G., Bhalang, K., Sigurdsson, A., Belfer, I., Goldman, D., Xu, K., Shabalina, S. A., Shagin, D., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi013 · Cited by 1,280 · cited 1×
“Likewise, individuals homozygous for the Met allele, associated with low COMT activity (affecting extracellular DA concentrations in the cortex) and therefore, restricted capacity to produce flexible phasic DA responses in striatum, are more sensitive to pain than those homozygous for the Val allele [174], and more li…”
Background
Cited by
Psychological processing in chronic pain: a neural systems approach
Simons, L. E., Elman, I., & Borsook, D. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.12.006 · Cited by 359
Electroencephalographic Patterns in Chronic Pain: A Systematic Review of the Literature
Pinheiro, E. S. D. S., Queirós, F. C. D., Montoya, P., Santos, C. L., Nascimento, M. A. D., Ito, C. H., Silva, M., Nunes Santos, D. B., Benevides, S., Miranda, J. G. V., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149085 · Cited by 261
Frontostriatal Gating of Tinnitus and Chronic Pain
Rauschecker, J. P., May, E. S., Maudoux, A., & Ploner, M. (2015) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.08.002 · Cited by 253
Pain, decisions, and actions: a motivational perspective
Wiech, K., & Tracey, I. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00046 · Cited by 188
Chang, P.-C., Pollema-Mays, S. L., Centeno, M. V., Procissi, D., Contini, M., Baria, A. T., Martina, M., & Apkarian, A. V. (2014) · Pain · doi:10.1016/j.pain.2014.02.019 · Cited by 161
“Moreover, in patients with central disorders such as schizophrenia, Parkinson’s disease, substance abuse, and mood and anxiety disorders, pain sensitivity is altered, presumably as a consequence of changes in the dopaminergic system [1,42,71], and animal studies implicate dopamine in acute and neuropathic conditions […”
BackgroundLi, C., Sugam, J. A., Lowery-Gionta, E. G., McElligott, Z. A., McCall, N. M., Lopez, A. J., McKlveen, J. M., Pleil, K. E., & Kash, T. L. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.12 · Cited by 161
Stubbs, B., Thompson, T., Acaster, S., Vancampfort, D., Gaughran, F., & Correll, C. U. (2015) · Pain · doi:10.1097/j.pain.0000000000000304 · Cited by 141
“Third, alterations in the cortical dopamine system and higher vulnerability of COMT Met allele may account for reduced pain sensitivity in people with schizophrenia.(27) Fourth, there may also be decreased primary sensory-discriminative pain processing functioning.”
BackgroundDoes the kappa opioid receptor system contribute to pain aversion?
Cahill, C. M., Taylor, A. M. W., Cook, C., Ong, E., Morón, J. A., & Evans, C. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00253 · Cited by 105
Stubbs, B., Mitchell, A. J., De Hert, M., Correll, C. U., Soundy, A., Stroobants, M., & Vancampfort, D. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.017 · Cited by 92
“striatal dopamine compared to healthy people and exhibit an increased amphetamine-induced striatal dopamine release than controls (Jarcho et al., 2012).”
BackgroundInfluentialLeitl, M. D., Onvani, S., Bowers, M. S., Cheng, K., Rice, K. C., Carlezon, W. A., Banks, M. L., & Negus, S. S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.236 · Cited by 87
Days With Pain and Substance Use Disorders: Is There an Association?
Edlund, M. J., Sullivan, M. D., Han, X., & Booth, B. M. (2013) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e318270fa77 · Cited by 39
Subliminal (latent) processing of pain and its evolution to conscious awareness
Borsook, D., Youssef, A. M., Barakat, N., Sieberg, C. B., & Elman, I. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.015 · Cited by 21
Metadata
- Authors
- Jarcho, J. M., Mayer, E. A., Jiang, Z. K., Feier, N. A., & London, E. D.
- Venue
- Pain
- Published
- 2012-04
- Volume
- 153
- Issue
- 4
- Pages
- 744-754
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2170447689
- Cited by
- 158
- References
- 38
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.